P1101 + Ribavirin

DRUG2 trials

Sponsors

PharmaEssentia

Conditions

Chronic Hepatitis C Virus InfectionHepatitis C, Chronic

Phase 1

The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection

CompletedNCT04774107

PharmaEssentiaHepatitis C, Chronic

Start: 2020-11-26End: 2022-07-18Updated: 2022-08-30

Phase 3

Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

CompletedNCT04382937

PharmaEssentiaChronic Hepatitis C Virus Infection

Start: 2016-01-12End: 2020-07-15Updated: 2022-01-18